Skip to main content

Advertisement

Log in

Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Glucagon-like peptide 2 (GLP-2) is a 33-amino acid gut peptide that leads to villus hyperplasia and altered gene expression.We examined the effect of chronically administered GLP-2 on diurnal gene expression rhythms using the Na+/glucose cotransporter 1 (SGLT1) as the index. Animals were treated with [Gly2]GLP-2 (twice daily; 1μg/g body weight) or vehicle (control) for 10 days. Rats were killed at either 3 hr or 9 hr after light onset (ZT3 and ZT9, respectively), an interval during which SGLT1 expression exhibits a robust induction. SGLT1 mRNA expression was assessed by Northern blotting and in situ hybridization. SGLT1 protein was examined by immunofluorescence and Western blotting. Tissues from GLP-2-treated rats had increased villus height, crypt depth, and proliferation index (P < 0.05). GLP-2 administration did not alter the diurnal increase in mRNA levels of SGLT1, GLUT2, or GLUT5. However, in GLP-2-treated rats, the SGLT1 protein amount increased at both ZT3 and ZT9. Moreover, SGLT1 was preferentially localized to the apical membranes in this group. GLP-2 does not adversely affect the diurnal expression rhythm of SGLT1 and appears to increase membrane expression of the protein. These biological actions of GLP-2 may contribute to its therapeutic value in intestinal diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ: Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 273:E77–E84, 1997

    Article  CAS  Google Scholar 

  2. Drucker DJ: Glucagon-like peptide 2. J Clin Endocrinol Metab 86:1759–1764, 2001

    CAS  PubMed  Google Scholar 

  3. Chance WT, Foley-Nelson T, Thomas I, Balasubramaniam A: Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. Am J Physiol 273:G559–G563, 1997

    CAS  PubMed  Google Scholar 

  4. Drucker DJ, Yusta B, Boushey RP, DeForest L, Brubaker PL: Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am J Physiol 276: G79–G91, 1999

    CAS  PubMed  Google Scholar 

  5. Scott RB, Kirk D, MacNaughton WK, Meddings JB: GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 275:G911–G921, 1998

    Article  CAS  Google Scholar 

  6. Boushey RP, Yusta B, Drucker DJ: Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am J Physiol 277:E937–E947, 1999

    Article  CAS  Google Scholar 

  7. Tavakkolizadeh A, Shen R, Abraham P, Kormi N, Seifert P, Edelman ER, Jacobs DO, Zinner MJ, Ashley SW, Whang EE: Glucagon-like peptide 2: A new treatment for chemotherapy-induced enteritis. J Surg Res 91:77–82, 2000

    Article  CAS  Google Scholar 

  8. Cheeseman CI: Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol 273:R1965–R1971, 1997

    CAS  PubMed  Google Scholar 

  9. Rhoads DB, Rosenbaum DH, Unsal H, Isselbacher KJ, Levitsky LL: Circadian periodicity of intestinal Na+/glucose cotransporter 1 mRNA levels is transcriptionally regulated. J Biol Chem 273:9510–9516, 1998

    Article  CAS  Google Scholar 

  10. Tavakkolizadeh A, Berger UV, Shen KR, Levitsky LL, Zinner MJ, Hediger MA, Ashley SW, Whang EE, Rhoads DB: Diurnal rhythmicity in intestinal SGLT-1 function, V(max), and mRNA expression topography. Am J Physiol Gastrointest Liver Physiol 280:G209–G215, 2001

    Article  CAS  Google Scholar 

  11. Xiao Q, Boushey RP, Drucker DJ, Brubaker PL: Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117:99–105, 1999

    Article  CAS  Google Scholar 

  12. Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C: Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18:2180–2189, 2003

    Article  CAS  Google Scholar 

  13. Ramsanahie A, Duxbury MS, Grikscheit TC, Perez A, Rhoads DB, Gardner-Thorpe J, Ogilvie J, Ashley SW, Vacanti JP, Whang EE: Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol 285:G1345–G1352, 2003

    Article  CAS  Google Scholar 

  14. Rand EB, Depaoli AM, Davidson NO, Bell GI, Burant CF: Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5. Am J Physiol 264:G1169–G1176, 1993

    CAS  PubMed  Google Scholar 

  15. Ercolani L, Florence B, Denaro M, Alexander M: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263:15335–15341, 1988

    CAS  PubMed  Google Scholar 

  16. Hirayama BA, Wright EM: Glycosylation of the rabbit intestinal brush border Na+/glucose cotransporter. Biochim Biophys Acta 1103:37–44, 1992

    Article  CAS  Google Scholar 

  17. Berger UV, Hediger MA: Differential distribution of the glutamate transporters GLT-1 and GLAST in tanycytes of the third ventricle. J Comp Neurol 433:101–114, 2001

    Article  CAS  Google Scholar 

  18. Burant CF, Flink S, DePaoli AM, Chen J, Lee WS, Hediger MA, Buse JB, Chang EB: Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. J Clin Invest 93:578–585, 1994

    Article  CAS  Google Scholar 

  19. Hwang ES, Hirayama BA, Wright EM: Distribution of the SGLT1 Na+/glucose cotransporter and mRNA along the crypt-villus axis of rabbit small intestine. Biochem Biophys Res Commun 181:1208–1217, 1991

    Article  CAS  Google Scholar 

  20. Uribe JM, Barrett KE: Nonmitogenic actions of growth factors: An integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology 112:255–268, 1997

    CAS  PubMed  Google Scholar 

  21. Ferraris RP: Dietary and developmental regulation of intestinal sugar transport. Biochem J 360:265–276, 2001

    Article  CAS  Google Scholar 

  22. Wright EM: I. Glucose galactose malabsorption. Am J Physiol 275:G879–G882, 1998

    CAS  PubMed  Google Scholar 

  23. Desjeux JF Wright EM: [30 years’ work on congenital glucose and galactose malabsorption: From phenotype to genotype]. Ann Gastroenterol Hepatol (Paris) 29:263–266 (discussion 266–268), 1993

    CAS  Google Scholar 

  24. Loo DD, Wright EM, Zeuthen T: Water pumps. J Physiol 542:53–60, 2002

    Article  CAS  Google Scholar 

  25. Tavakkolizadeh A, Shen R, Jasleen J, Soybel DI, Jacobs DO, Zinner MJ, Ashley SW, Whang EE: Effect of growth hormone on intestinal Na+/glucose cotransporter activity. JPEN J Parenter Enteral Nutr 25:18–22, 2001

    Article  CAS  Google Scholar 

  26. Lescale-Matys L, Dyer J, Scott D, Freeman TC, Wright EM, Shirazi-Beechey SP: Regulation of the ovine intestinal Na+/glucose co-transporter (SGLT1) is dissociated from mRNA abundance. Biochem J 291 (Pt 2):435–440, 1993

    Article  CAS  Google Scholar 

  27. Shirazi-Beechey SP, Gribble SM, Wood IS, Tarpey PS, Beechey RB, Dyer J, Scott D, Barker PJ: Dietary regulation of the intestinal sodium-dependent glucose cotransporter (SGLT1). Biochem Soc Trans 22:655–658, 1994

    Article  CAS  Google Scholar 

  28. Yoshida A, Takata K, Kasahara T, Aoyagi T, Saito S, Hirano H: Immunohistochemical localization of Na(+)-dependent glucose transporter in the rat digestive tract. Histochem J 27:420–426, 1995

    Article  CAS  Google Scholar 

  29. Brubaker PL, Izzo A, Hill M, Drucker DJ: Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol 272:E1050–E1058, 1997

    CAS  PubMed  Google Scholar 

  30. Martin GR, Wallace LE, Sigalet DL: Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 286:G964–G972, 2004

    Article  CAS  Google Scholar 

  31. Wright EM, Turk E, Zabel B, Mundlos S, Dyer J: Molecular genetics of intestinal glucose transport. J Clin Invest 88:1435–1440, 1991

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David B. Rhoads.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramsanahie, A.P., Berger, U.V., Zinner, M.J. et al. Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression. Dig Dis Sci 49, 1731–1737 (2004). https://doi.org/10.1007/s10620-004-9561-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-004-9561-8

Navigation